ClinicalTrials.Veeva

Menu
Q

Quirino Memorial Medical Center | Clinical Trial Unit

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Aspirin
Ipratropium
C21
GT0918
Avibactam
Proxalutamide
Rivaroxaban
Astegolimab
MTZ
Vitamin K

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 14 total trials

A Global Phase III Clinical Trial of Recombinant COVID- 19 Vaccine (Sf9 Cells)

This Phase III study is a global multicenter, randomized, double-blind,placebo controlled clinical trial to evaluate the efficacy, safety, and immuno...

Active, not recruiting
COVID-19
Biological: Recombinant COVID-19 vaccine (Sf9 cells)
Other: Placebo control

This study will evaluate the efficacy and safety of astegolimab compared with placebo in participants with chronic obstructive pulmonary disease (COP...

Enrolling
Chronic Obstructive Pulmonary Disease (COPD)
Drug: Astegolimab
Drug: Placebo

This Phase 1, randomized, observer-blind, dose-ranging clinical study is evaluating 6 different formulations of MF59-adjuvanted and non-adjuvanted H2...

Enrolling
Influenza, Human
Infection Viral
Biological: Intermediate dose A/H2N3c + standard dose MF59
Biological: High dose A/H2N3c + standard dose MF59

This is a Phase 3, randomized, parallel-group, comparator-controlled, observer-blind, multicenter study of immunogenicity and safety in approximately...

Active, not recruiting
Influenza, Human
Biological: licensed QIV1
Biological: licensed QIV2

Trial sponsors

Boehringer Ingelheim logo
Seqirus logo
P
Fresenius Kabi logo
GlaxoSmithKline (GSK) logo
K
Pfizer logo
Population Health Research Institute (PHRI) logo
Roche logo
V

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems